Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123278322 | 12327832 | 2 | F | 2013 | 20160825 | 20160503 | 20160901 | EXP | US-DSJP-DSU-2016-115145 | DAIICHI | 0.00 | Y | 0.00000 | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123278322 | 12327832 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | U | 21286 | 20 | MG | TABLET | QD | ||||||
| 123278322 | 12327832 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | ||||||
| 123278322 | 12327832 | 3 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG, 3 TIMES PER 1WK | 0 | 1 | MG | TABLET | TIW | ||||||
| 123278322 | 12327832 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 2 MG, QD | 0 | 2 | MG | TABLET | QD | ||||||
| 123278322 | 12327832 | 5 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 123278322 | 12327832 | 6 | C | DILTIAZEM. | DILTIAZEM | 1 | 120 MG, QD | 0 | 120 | MG | QD | ||||||||
| 123278322 | 12327832 | 7 | C | NORTRIPTYLINE HCL | NORTRIPTYLINE HYDROCHLORIDE | 1 | Oral | 50 MG, AT BED TIME, QD | 0 | 50 | MG | CAPSULE | QD | ||||||
| 123278322 | 12327832 | 8 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | 50000 IU, ONCE EVERY 1 WK | 0 | 50000 | IU | CAPSULE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123278322 | 12327832 | 1 | Hypertension |
| 123278322 | 12327832 | 3 | Product used for unknown indication |
| 123278322 | 12327832 | 4 | Product used for unknown indication |
| 123278322 | 12327832 | 5 | Product used for unknown indication |
| 123278322 | 12327832 | 6 | Product used for unknown indication |
| 123278322 | 12327832 | 7 | Product used for unknown indication |
| 123278322 | 12327832 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123278322 | 12327832 | OT |
| 123278322 | 12327832 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123278322 | 12327832 | Anal fissure | |
| 123278322 | 12327832 | Gastrointestinal haemorrhage | |
| 123278322 | 12327832 | Haematemesis | |
| 123278322 | 12327832 | Haemorrhoids | |
| 123278322 | 12327832 | Helicobacter infection | |
| 123278322 | 12327832 | Hepatic enzyme increased | |
| 123278322 | 12327832 | Hypotension | |
| 123278322 | 12327832 | Irritable bowel syndrome | |
| 123278322 | 12327832 | Malabsorption | |
| 123278322 | 12327832 | Renal injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123278322 | 12327832 | 1 | 201301 | 0 |